MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
基本信息
- 批准号:6665523
- 负责人:
- 金额:$ 235.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The University of Texas M. D. Anderson
Cancer Center is proposing a Specialized Program of Research Excellence
(SPORE) in head and neck cancer. The primary goal of this research program is
to cultivate and facilitate innovative and significant translational research
in the biologic, genetic and clinical aspects of early detection, prevention
and treatment of head and neck cancer. These efforts will lead to changes in
clinical practice that favorably impact mortality and morbidity of patients
with cancer and decrease the incidence of head and neck cancer. The
multidisciplinary group of distinguished investigators assembled for this
research program will accomplish this goal through effective and collaborative
integration of laboratory, epidemiologic and clinical investigations. Such
activity will further our understanding of genetic susceptibility and the
tumorigenic process in target tissue, leading to novel, molecularly-targeted
strategies for the treatment and prevention of head and neck cancer. As
outlined below, the program is designed with five research projects and three
core resources, as well as programs for developmental research and career
development. The research projects are designed to target specific areas
important in head and neck cancer, as well as cancers at other disease sites.
Project 1: Genetic Susceptibility Markers in Surrogate and Target Tissues
Project 2: Targeting Angiogenesis for Therapy of Head and Neck Cancer
Project 3: Targeting EGFR for Chemoprevention of Head and Neck Cancer
Project 4: Targeting the p53 Pathway for Reversal of Oral Premalignancy
Project 5: Targeting Induction of Apoptosis for Therapy of Head and Neck
Cancer
Core : Biostatistics and Data Management
Core : Tissue Procurement and Pathology
Developmental Research Program and Career Development Program
Through this research program, our research team will make a significant
impact on prevention and clinical care of patients with head and neck cancer.
We will bring all of our resources to bear on this problem.
描述(由申请人提供):德克萨斯大学安德森博士
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Waun Ki Hong其他文献
Testis Tumor Markers: How Accurate are They?
- DOI:
10.1016/s0022-5347(17)55155-1 - 发表时间:
1981-05-01 - 期刊:
- 影响因子:
- 作者:
Ralph deVere White;Steven Karian;Waun Ki Hong;Carl A. Olsson - 通讯作者:
Carl A. Olsson
Pharmacology, Clinical Efficacy and Adverse Effects of Vindesine Sulfate, A New Vinca Alkaloid
新长春花生物碱硫酸长春地辛的药理、临床疗效及不良反应
- DOI:
10.1002/j.1875-9114.1983.tb03269.x - 发表时间:
1983 - 期刊:
- 影响因子:0
- 作者:
R. J. Cersosimo;R. Bromer;J. Licciardello;Waun Ki Hong - 通讯作者:
Waun Ki Hong
The incidence of hypercalcemia in squamous cell carcinoma of the head and neck.
头颈部鳞状细胞癌高钙血症的发生率。
- DOI:
- 发表时间:
1984 - 期刊:
- 影响因子:0
- 作者:
E. Dorman;H. Yang;C. Vaughan;W. Hong;Waun Ki Hong;Strong Ms - 通讯作者:
Strong Ms
Rapidly Expanding Retroperitoneal Mass
- DOI:
10.1016/s0022-5347(17)56019-x - 发表时间:
1980-04-01 - 期刊:
- 影响因子:
- 作者:
Carl A. Olsson;Enrique Soto;Stephen Gerzof;Waun Ki Hong;Neal K. Anderson - 通讯作者:
Neal K. Anderson
Familial intraocular malignant melanoma. A Case Report
家族性眼内恶性黑色素瘤。
- DOI:
- 发表时间:
1978 - 期刊:
- 影响因子:6.2
- 作者:
Glenn J. Green;Waun Ki Hong;J. Everett;Rakesh Bhutani;Robert M. Amick - 通讯作者:
Robert M. Amick
Waun Ki Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Waun Ki Hong', 18)}}的其他基金
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
- 批准号:
7112910 - 财政年份:2002
- 资助金额:
$ 235.07万 - 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
- 批准号:
6531499 - 财政年份:2002
- 资助金额:
$ 235.07万 - 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
- 批准号:
6801959 - 财政年份:2002
- 资助金额:
$ 235.07万 - 项目类别:
MD Anderson Cancer Center SPORE in Head and Neck Cancer
MD 安德森癌症中心 SPORE 在头颈癌中的应用
- 批准号:
6951910 - 财政年份:2002
- 资助金额:
$ 235.07万 - 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
- 批准号:
6646587 - 财政年份:2001
- 资助金额:
$ 235.07万 - 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
- 批准号:
6793673 - 财政年份:2001
- 资助金额:
$ 235.07万 - 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
- 批准号:
6360029 - 财政年份:2001
- 资助金额:
$ 235.07万 - 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
- 批准号:
6949040 - 财政年份:2001
- 资助金额:
$ 235.07万 - 项目类别:
Impact of Smoking on Lung Cancer Chemoprevention
吸烟对肺癌化学预防的影响
- 批准号:
6522695 - 财政年份:2001
- 资助金额:
$ 235.07万 - 项目类别:
CHEMOPREVENTION OF SECOND PRIMARY TUMORS WITH 13-CIS RETINOIC ACID
用 13-顺式视黄酸化学预防第二原发肿瘤
- 批准号:
6300362 - 财政年份:2000
- 资助金额:
$ 235.07万 - 项目类别: